Search | Page 37 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... RATIONALE: A peripheral stem cell transplant may be able to replace blood-forming cells that were destroyed by chemotherapy and radiation therapy, or ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  2. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... RATIONALE: Midostaurin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in ... patients who have received prior autologous or allogeneic stem cell transplantation are not eligible; patients may have received 1 or 2 ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  3. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells in conjunction with the immunomodulating drug, ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  4. Lisa Minter, MD

    ... aplastic anemia , results in the destruction of blood stem and progenitor cells in the bone marrow. One subset of these cells, CD4 T cells, requires the ...

    Grant Recipient last updated 08/18/2014 - 10:07am.

  5. Immunosuppressive Therapy

    ... may prevent the bone marrow from making normal blood cells. Immunosuppressive therapy uses medicines to keep the immune system from ... are turned off by the cyclosporine, they stop attacking stem cells in the bone marrow. Then the stem cells may be able to ...

    Page last updated 01/20/2015 - 4:45pm.

  6. Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

    ... with hematologic malignancies undergoing hematopoietic stem cell transplant (HSCT). Biological therapies, such as sirolimus and ... suppress the immune system in different ways and stop tumor cells from growing. Giving sirolimus and mycophenolate mofetil after ...

    Clinical Trial last updated 05/03/2016 - 11:35am.

  7. Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

    ... salvage therapy, or has relapsed after hematopoietic stem cell transplant (HSCT). Participant disease tested positive for ... on Day 8 of the first cycle. If they do not have leukemia cells in their spinal fluid, they will receive only one IT chemotherapy per ...

    Clinical Trial last updated 06/06/2016 - 10:04am.

  8. Medical Resources

    ... education & awareness about using umbilical cord blood stem cells as a treatment for disease. Salute To Life ...

    Page last updated 08/20/2015 - 8:34am.

  9. Dr. Vivienne Rebel reports on a study of the relationship between gene mutations and overall survival after stem cell transplant

    ... patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation. ... isolated from bone marrow or peripheral blood cells from 87 patients prior to undergoing a blood- stem cell transplant ...

    Research Review last updated 05/02/2016 - 9:16am.

  10. Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

    ... side effects and best dose of selinexor when given after stem cell transplant in treating patients with acute myeloid leukemia that ... cancer growth by blocking an enzyme, which may cause cancer cells to die and also kill cells that cause the cancer to grow, which commonly ...

    Clinical Trial last updated 04/29/2016 - 10:38am.